Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk

General Practitioners Recognizing Alcohol Dependence: A Large Cross-Sectional Study in 6 European Countries

(2015) J. Rehm et al.   ANNALS OF FAMILY MEDICINE

Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients

(2015) Henri-Jean Aubin et al.   EUROPEAN ADDICTION RESEARCH

Transitioning Into and Out of Problem Drinking Across Seven Years*

(2015) Kevin L. Delucchi et al.   Journal of Studies on Alcohol and Drugs

Elements That Define Recovery: The Experiential Perspective

(2015) Lee Ann Kaskutas et al.   Journal of Studies on Alcohol and Drugs

Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis

(2014) M. Roerecke et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Doing it by numbers: A simple approach to reducing the harms of alcohol

(2014) David J Nutt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

(2014) Wim van den Brink et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Prevalence of and Potential Influencing Factors for Alcohol Dependence in Europe

(2014) Jürgen Rehm et al.   EUROPEAN ADDICTION RESEARCH

A Predictive Microsimulation Model to Estimate the Clinical Relevance of Reducing Alcohol Consumption in Alcohol Dependence

(2014) Clément François et al.   EUROPEAN ADDICTION RESEARCH

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

(2014) P. Laramee et al.   BMJ Open

Alcohol use disorders and mortality: a systematic review and meta-analysis

(2013) Michael Roerecke et al.   ADDICTION

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies

(2013) W. van den Brink et al.   ALCOHOL AND ALCOHOLISM

Reduction of Drinking in Problem Drinkers and All-Cause Mortality

(2013) J. Rehm et al.   ALCOHOL AND ALCOHOLISM

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

(2013) Antoni Gual et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Reduction of Alcohol Consumption and Subsequent Mortality in Alcohol Use Disorders

(2013) Michael Roerecke et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

(2012) Karl Mann et al.   BIOLOGICAL PSYCHIATRY

Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union

(2012) J. Rehm et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The relation between different dimensions of alcohol consumption and burden of disease: an overview

(2010) Jürgen Rehm et al.   ADDICTION

Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups

(2010) N. Heather et al.   ALCOHOL AND ALCOHOLISM